Recent studies show α-eleostearic acid and its methyl ester induce ferroptosis in senescent cells, reducing inflammation and improving muscle function in aged mice without toxicity, with clinical tri...
Recent breakthroughs in senolytic and senomorphic therapies, including polyunsaturated lipids inducing ferroptosis, are advancing clinical trials for age-related diseases, with a focus on safety and b...
Zhang et al. (2026) discovered that α-eleostearic acid and its methyl ester act as novel senolytic agents by inducing ferroptosis in senescent cells, achieving over 80% clearance with minimal toxicit...
Exploring recent advances in senolytic and senomorphic therapies, including dasatinib-quercetin and immune-based approaches, to combat age-related diseases like Alzheimer’s and sarcopenia. New t...
Recent studies on hydra’s negligible senescence overturn traditional aging models, suggesting aging is adaptable and offering clues for anti-aging biotech interventions. New research reveals hyd...
Recent studies highlight autophagy’s conflicting roles in aging: protective early on but sustaining harmful senescent cells under stress, with the threshold model guiding new clinical approaches...
Recent studies from the LEV Foundation and Brian Kennedy’s team show that combining therapies targeting multiple age-related damages can significantly extend lifespan and healthspan in preclinic...
Recent studies reveal mesenchymal stromal cells transfer healthy mitochondria via endocytosis, combating mitochondrial dysfunction in aging and diseases like osteoporosis, with fenofibrate enhancing e...
A new study reveals ANKRD1 gene therapy improves memory in aged mice by enhancing neurogenesis, signaling potential for anti-aging treatments targeting brain health. ANKRD1 gene therapy boosts memory ...
Recent advancements in cellular reprogramming, including significant funding and clinical trials, are transforming anti-aging science by targeting root causes of age-related diseases. Cellular reprogr...
